A sealed tube combines DNA copying with CRISPR-based detection to screen for the virus using portable equipment.
The test combines enzymatic recombinase amplification, which copies target DNA at a constant temperature, with CRISPR/Cas12a, a programmable system that produces a fluorescence signal when it recognizes the target. A two-layer tube keeps the two reactions apart during the initial amplification stage and allows them to mix later without opening the tube.
The assay targets the conserved B646L gene of African swine fever virus. In tests, it did not react with DNA or genetic material from six other common swine pathogens, and its fluorescence could be monitored with a portable analyzer connected to a smartphone.
What the test detected
The assay detected the plasmid standard containing the target viral gene down to 1.21 × 10¹ copies per microliter. It showed no cross-reactivity with porcine epidemic diarrhea virus, porcine reproductive and respiratory syndrome virus, pseudorabies virus, Senecavirus A, classical swine fever virus or porcine circovirus type 2. Repeatability tests had coefficients of variation below 6.9% within runs and 6.75% between runs. In simulated clinical serum samples, the test correctly identified all positive and negative samples. The sealed, dual-layer design separated amplification from CRISPR/Cas12a detection before allowing the reactions to mix, reducing the need to open the tube after amplification.
// Source
Scientific Reports · 2026 · DOI: 10.1038/s41598-026-72034-8
Authors: Liwei Xu, Siyi Wang, Desheng Zhang, Yibin Yang, Mengli Man, Wentao Bai, Yu Zhao, Jiayi Xue, Juan Bai, Ping Jiang, Zhongjie Fei
Institutions: Nanjing Agricultural University